Table 3.
Author | Items | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||
Neck pain | ||||||||||||
Palmer et al., 2023 [42] | Y | Y | N | Y | N | N | Y | Y | N | N | N | 4/10 |
Schwerla et al., 2008 [41] | Y | Y | Y | Y | Y | N | N | Y | N | Y | Y | 7/10 |
Low-back pain | ||||||||||||
Auger et al., 2021 [44] | Y | Y | N | Y | Y | N | N | Y | N | N | N | 4/10 |
Nguyen et al., 2021 [43] | Y | Y | Y | Y | Y | N | N | N | N | Y | Y | 6/10 |
Hensel et al., 2015 [49] | Y | Y | Y | Y | Y | N | N | N | Y | Y | Y | 7/10 |
Licciardone et al., 2013 [47] | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | N | 8/10 |
Licciardone et al., 2010 [48] | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 8/10 |
Licciardone et al., 2003 [46] | Y | Y | Y | Y | Y | N | Y | Y | N | Y | Y | 8/10 |
Gibson et al., 1985 [45] | Y | Y | N | Y | N | N | Y | Y | N | N | Y | 5/10 |
1, eligibility criteria; 2, random allocation; 3, concealed allocation; 4, similarity at baseline; 5, blinding of participants; 6, blinding of therapists; 7, blinding of assessors; 8, measures of at least one key outcome from at least 85% of participants initially allocated to groups; 9, intention to treat analysis; 10, between-group comparison; 11, point measures and measures of variability. 1 = Yes (1 point), 0 = No (0 point), maximum score = 10 (criterion 1 is not included in scores).